Filing Flows

Filing Flows › Quest Diagnostics (DGX) › Q2 2026 › vs Q2 2025

Quest Diagnostics (DGX) Q2 2026 vs Q2 2025 (year over year)

Quest Diagnostics's revenue rose $282M (+10%) from $2.8B in Q2 2025 to $3.0B in Q2 2026. The biggest changes: DIS business +$279M (+10%); All other operating segments +$3.0M (+5%). Operating margin 15.1% against 15.9% (-0.8 pts).

Quest Diagnostics, Q2 2026: revenue $3.0B (+10% year over year), operating margin 15.1%, net earnings $320M, operating cash flow $597M. The chart draws each line against Q2 2025, the increases inside each band.

Quest Diagnostics: what changed, Q2 2026 vs Q2 2025Quest Diagnostics: what changed, Q2 2026 vs Q2 2025DIS business$279MCosts & expenses$261MCost of revenue$198MOperating cash flow$53.0MSG&A$43.0MNet earnings$38.0MCapital expenditures$30.0MPre-tax earnings$29.0MFree cash flow (OCF − capex)$23.0MOperating profit$21.0M

Margins

Q2 2026Q2 2025Change
Operating margin15.1%15.9%-0.8 pts
Net margin10.5%10.2%+0.3 pts
Free cash flow margin15.1%15.8%-0.7 pts

Every line

LineQ2 2026Q2 2025Change%
DIS business$3.0B$2.7B$279M+10%
All other operating segments$65.0M$62.0M$3.0M+5%
Revenue$3.0B$2.8B$282M+10%
Operating profit$459M$438M$21.0M+5%
Costs & expenses$2.6B$2.3B$261M+11%
Pre-tax earnings$422M$393M$29.0M+7%
Other expense, net$37.0M$45.0M−$8.0M-18%
Cost of revenue$2.0B$1.8B$198M+11%
SG&A$529M$486M$43.0M+9%
Other operating costs$39.0M$19.0M$20.0M+105%
Net earnings$320M$282M$38.0M+13%
Minority interests$14.0M$14.0M$00%
Income tax$88.0M$97.0M−$9.0M-9%
Depreciation & amortization$146M$143M$3.0M+2%
Share-based compensation$23.0M$21.0M$2.0M+10%
Working capital & other$108M$98.0M$10.0M+10%
Operating cash flow$597M$544M$53.0M+10%
Free cash flow (OCF − capex)$459M$436M$23.0M+5%
Capital expenditures$138M$108M$30.0M+28%

Questions

How much did Quest Diagnostics's revenue grow year over year in Q2 2026?

Quest Diagnostics's revenue rose $282M (+10%) from $2.8B in Q2 2025 to $3.0B in Q2 2026.

What drove Quest Diagnostics's revenue change in Q2 2026?

DIS business +$279M (+10%); All other operating segments +$3.0M (+5%).

Q2 2026 results → · Compare in the interactive Sankey →